GEO Accession viewer

GSM821578	Peripheral blood mononuclear cells of 205-Cy5 post-treatment and 131-Cy3 pre-treatment dasatinib non-responder patient
GSM821579	Peripheral blood mononuclear cells of 195-Cy3 post-treatment and 148-Cy5 pre-treatment dasatinib non-responder patient
GSM821580	Peripheral blood mononuclear cells of 195-Cy5 post-treatment and 148-Cy3 pre-treatment dasatinib non-responder patient
GSM821581	Peripheral blood mononuclear cells of 235-Cy3 post-treatment and 155-Cy5 pre-treatment dasatinib non-responder patient
GSM821582	Peripheral blood mononuclear cells of 235-Cy5 post-treatment and 155-Cy3 pre-treatment dasatinib non-responder patient
GSM821583	Peripheral blood mononuclear cells of 221-Cy3 post-treatment and 136-Cy5 pre-treatment dasatinib responder patient
GSM821584	Peripheral blood mononuclear cells of 221-Cy5 post-treatment and 136-Cy3 pre-treatment dasatinib responder patient
GSM821585	Peripheral blood mononuclear cells of 240-Cy3 post-treatment and 150-Cy5 pre-treatment dasatinib responder patient
GSM821587	Peripheral blood mononuclear cells of 240-Cy5 post-treatment and 150-Cy3 pre-treatment dasatinib responder patient
GSM821592	Peripheral blood mononuclear cells of 234-Cy3 post-treatment and 152-Cy5 pre-treatment dasatinib responder patient
GSM821854	Peripheral blood mononuclear cells of 234-Cy5 post-treatment and 152-Cy3 pre-treatment dasatinib responder patient
GSM821861	Peripheral blood mononuclear cells of 128-Cy3 pre-treatment and 239-Cy5 post-treatment dasatinib non-responder patient
GSM821871	Peripheral blood mononuclear cells of 128-Cy5 pre-treatment and 239-Cy3 post-treatment dasatinib non-responder patient
GSM821906	Peripheral blood mononuclear cells of 131-Cy3 pre-treatment and 205-Cy5 post-treatment dasatinib non-responder patient
GSM821986	Peripheral blood mononuclear cells of 131-Cy5 pre-treatment and 205-Cy3 post-treatment dasatinib non-responder patient
GSM822130	Peripheral blood mononuclear cells of 148-Cy3 pre-treatment and 195-Cy5 post-treatment dasatinib non-responder patient
GSM822200	Peripheral blood mononuclear cells of 148-Cy5 pre-treatment and 195-Cy3 post-treatment dasatinib non-responder patient
GSM822210	Peripheral blood mononuclear cells of 155-Cy3 pre-treatment and 235-Cy5 post-treatment dasatinib non-responder patient
GSM822239	Peripheral blood mononuclear cells of 155-Cy5 pre-treatment and 235-Cy3 post-treatment dasatinib non-responder patient
GSM822240	Peripheral blood mononuclear cells of 136-Cy3 pre-treatment and 221-Cy5 post-treatment dasatinib responder patient
GSM822241	Peripheral blood mononuclear cells of 136-Cy5 pre-treatment and 221-Cy3 post-treatment dasatinib responder patient
GSM822266	Peripheral blood mononuclear cells of 150-Cy3 pre-treatment and 240-Cy5 post-treatment dasatinib responder patient
GSM822315	Peripheral blood mononuclear cells of 150-Cy5 pre-treatment and 240-Cy3 post-treatment dasatinib responder patient
GSM822324	Peripheral blood mononuclear cells of 152-Cy3 pre-treatment and 234-Cy5 post-treatment dasatinib responder patient
GSM822401	Peripheral blood mononuclear cells of 152-Cy5 pre-treatment and 234-Cy3 post-treatment dasatinib responder patient
GSM823429	Peripheral blood mononuclear cells of 136-Cy3 pre-treatment dasatinib responder patient
GSM823430	Peripheral blood mononuclear cells of 221-Cy5 post-treatment dasatinib responder patient
GSM823431	Peripheral blood mononuclear cells of 221-Cy3 post-treatment dasatinib responder patient
GSM823432	Peripheral blood mononuclear cells of 136-Cy5 pre-treatment dasatinib responder patient
GSM823433	Peripheral blood mononuclear cells of 148-Cy3 pre-treatment dasatinib responder patient
GSM823434	Peripheral blood mononuclear cells of 195-Cy5 post-treatment dasatinib responder patient
GSM823435	Peripheral blood mononuclear cells of 195-Cy3 post-treatment dasatinib responder patient
GSM823436	Peripheral blood mononuclear cells of 148-Cy5 pre-treatment dasatinib responder patient
GSM823437	Peripheral blood mononuclear cells of 150-Cy3 pre-treatment dasatinib responder patient
GSM823438	Peripheral blood mononuclear cells of 240-Cy5 post-treatment dasatinib responder patient
GSM823439	Peripheral blood mononuclear cells of 240-Cy3 post-treatment dasatinib responder patient
GSM823440	Peripheral blood mononuclear cells of 150-Cy5 pre-treatment dasatinib responder patient
GSM823441	Peripheral blood mononuclear cells of 152-Cy3 pre-treatment dasatinib responder patient
GSM823442	Peripheral blood mononuclear cells of 234-Cy5 post-treatment dasatinib responder patient
GSM823443	Peripheral blood mononuclear cells of 128-Cy3 pre-treatment dasatinib responder patient
GSM823444	Peripheral blood mononuclear cells of 239-Cy5 post-treatment dasatinib responder patient
GSM823445	Peripheral blood mononuclear cells of 239-Cy3 post-treatment dasatinib responder patient
GSM823446	Peripheral blood mononuclear cells of 128-Cy5 pre-treatment dasatinib responder patient
GSM823447	Peripheral blood mononuclear cells of 131-Cy3 pre-treatment dasatinib responder patient
GSM823448	Peripheral blood mononuclear cells of 205-Cy5 post-treatment dasatinib responder patient
GSM823449	Peripheral blood mononuclear cells of 205-Cy3 post-treatment dasatinib responder patient
GSM823450	Peripheral blood mononuclear cells of 131-Cy5 pre-treatment dasatinib responder patient
GSM823451	Peripheral blood mononuclear cells of 155-Cy3 pre-treatment dasatinib responder patient
GSM823452	Peripheral blood mononuclear cells of 235-Cy5 post-treatment dasatinib responder patient
GSM823453	Peripheral blood mononuclear cells of 235-Cy3 post-treatment dasatinib responder patient
GSM823454	Peripheral blood mononuclear cells of 155-Cy5 pre-treatment adasatinib responder patient